JBIO

Jade Biosciences, Inc. Common Stock
JBIO

Overview Fund Activity

56 hedge funds and large institutions have $434M invested in Jade Biosciences, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 4 closing their positions.

Holders
56
Holders Change
+5
Holders Change %
+9.8%
% of All Funds
0.97%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.12%
New
9
Increased
21
Reduced
18
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CAM
1
Cormorant Asset Management
Massachusetts
$38.6M
2
VA
2
VR Adviser
New York
$13.8M
3
IC
3
Ikarian Capital
Texas
$3.32M
4
GTC
4
Ghost Tree Capital
New York
$2.49M
5
LCM
5
Lynx1 Capital Management
Puerto Rico
$4.58M

Top Sellers

1
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$38.6M
2
SAM
2
Sectoral Asset Management
Quebec, Canada
$0
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$8.71M
4
BBA
4
Baker Bros. Advisors
New York
$32.8M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$1.33M
Name Market Value Shares Shares
Change 		Shares
Change %
Barclays
51
Barclays
United Kingdom
$6K 389 -3,635 -90%
CUAMC
52
China Universal Asset Management Company
China
$4K 229 +229 New
Daiwa Securities Group
53
Daiwa Securities Group
Japan
$1K 73 – –
CS
54
Credit Suisse
Switzerland
$1K 50 +39 New
SAM
55
Sectoral Asset Management
Quebec, Canada
– – -196,038 Closed
Jane Street
56
Jane Street
New York
– – -11,717 Closed
CPIG
57
Chicago Partners Investment Group
Illinois
– – -10,163 Closed
Wells Fargo
58
Wells Fargo
California
$0 28 -90 -76%
FCA
59
FinTrust Capital Advisors
South Carolina
– – -82 Closed
EI
60
Ellevest Inc
New York
$0 1 -12 -92%
CFGS
61
Concourse Financial Group Securities
Alabama
– – – –
1 2
3